<DOC>
	<DOCNO>NCT02553044</DOCNO>
	<brief_summary>Total 25 ( OH ) D currently use biomarker vitamin D status . However , debate whether total 25 ( OH ) D best marker use . It suggest free vitamin D may better may biologically available . There also uncertainties treat vitamin D deficiency . A single dose attractive certain patient dose requirement ongoing compliance , still clear best dose give . Also , recent study highlight high dose vitamin D supplementation may increase risk fall old population . The investigator believe study free vitamin D respond different bolus dos best way address current research gap , include best biomarker vitamin D status , mechanism vitamin D toxicity safe bolus dose treat deficiency . The investigator study change total free 25 ( OH ) D , also clinical response , three different bolus dos vitamin D ( 50 000IU , 150 000IU 500 000IU ) 84 vitamin D deficient postmenopausal woman , three month period 5 study visit . A concurrent control group 28 vitamin D sufficient postmenopausal woman also recruit . This allow investigator determine total free vitamin D change bolus dose whether disproportionate rise free 25 ( OH ) D high dos may lead hypercalcemia fall .</brief_summary>
	<brief_title>Change Free 25 ( OH ) D After High Dose Vitamin D Deficient Postmenopausal Women</brief_title>
	<detailed_description>The commonly use measurement vitamin D status serum 25-hydroxyvitamin D ( 25 ( OH ) D ) . However clear consensus level 25 ( OH ) D require protect adverse effect deficiency . One approach define deficiency level 25 ( OH ) D secondary physiological response , rise parathyroid hormone . However , approach yield clear answer . Total 25 ( OH ) D 30nmol/l always associate increased parathyroid hormone ( PTH ) response , total 25 ( OH ) D PTH always respond vitamin D supplementation . This suggest total 25 ( OH ) D measurement may best biological marker vitamin D status . Vitamin D metabolites bound protein circulation : around 85-90 % 25 ( OH ) D bound vitamin D bind protein ( DBP ) , 10-15 % bound albumin , le 1 % free form . DBP protect 25 ( OH ) D degradation allow circulate store accumulate . The free hormone hypothesis suggest unbound 'free ' portion protein bound hormone biologically active , measured accurate assessment hormone availability . Calculated free 25 ( OH ) D concentration show well correlate bone mineral density ( BMD ) total 25 ( OH ) D healthy population closely related PTH patient end stage renal disease . The binding capacity DBP may overwhelm situation . In female participant treat oral dose 500,000 IU annually 3 year increase risk fall fracture particularly mark three month period dose . It propose vitamin D toxicity possible hypercalcaemia period due binding capacity DBP overwhelm large increase 25 ( OH ) D relatively great increase free 25 ( OH ) D. However , free vitamin D calcium measure study , yet evidence support hypothesis . The investigator study change total free 25 ( OH ) D , clinical response three different bolus dos vitamin D ( 50,000 unit , 150,000 unit 500,000 unit ) 84 vitamin D deficient ( &lt; 30nmol/l ) postmenopausal woman three month . This allow investigator determine free total 25 ( OH ) D change bolus dose whether disproportionately high rise free 25 ( OH ) D high dos . This also generate well understanding optimum bolus dose treatment vitamin D deficiency whether free 25 ( OH ) D may better marker vitamin D status situation . Aims study : - To determine effect three different vitamin D bolus dos free 25 ( OH ) D total 25 ( OH ) D vitamin D deficient post-menopausal woman . - To determine effect different vitamin D bolus dose parameter calcium metabolism , bone turnover marker physical function vitamin D deficient post-menopausal woman .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Caucasian 25 ( OH ) D &lt; 30nmol/l treatment group 25 ( OH ) D &gt; 50nmol/l control group BMI 20 kg/m2 30kg/m2 55 year postmenopausal ( least 5 year since last menstrual period ) Able willing participate study provide write informed consent . History long term immobilization ( duration great three month ) Prediagnosed diabetes mellitus High trauma fracture low trauma fracture less one year prior recruitment History current condition know affect vitamin D bone metabolism , include : Chronic renal disease Malabsorption syndromes Diagnosed endocrine disorder Hypercalcaemia Diagnosed restrictive eating disorder Use medication treatment know affect vitamin D bone metabolism bisphosphonates antiepileptic medication . Alcohol intake great 21 unit per week Holiday significant sunlight exposure last six week Planned sun holiday within study period Abnormal clinical laboratory parameter assess clinically significant PI .</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>